Drug intelligence / Profile preview

Vincamine

Development stage
Unknown
Lead developer
E. Schlittler
Modality
Small Molecules
Administration
Oral
01

Overview

Vincamine is an indole alkaloid derived from the leaves of the Vinca minor (lesser periwinkle) plant. It is recognized for its cognitive-enhancing and vasodilatory effects, particularly in cerebral blood vessels. Classified as a nootropic and a vasodilator, it is used in Europe as a prescription medicine for conditions such as cerebrovascular insufficiency, age-related cognitive decline, Alzheimer's disease, and other forms of dementia. In the United States, it is sold as a dietary supplement. Its primary mechanism of action involves enhancing cerebral blood flow by inhibiting phosphodiesterase, which leads to increased cyclic adenosine monophosphate (cAMP) levels and subsequent vasodilation. Vincamine also exhibits neuroprotective properties by reducing oxidative stress and mitigating excitotoxicity, and may modulate neurotransmitter systems like dopamine and serotonin. Additionally, it has been investigated for its anticancer potential and has shown hypoglycemic and hypolipidemic activities.

Brand names
OxybralVinoxinVincaprontCerebroxineDevincanPervincamineMinorinNovicetPervalSostenilTripervanAngiopacEquipur
Other names
monoterpenoid indole alkaloid
02

Targets

NF-κBGluR (Glutamate receptors)AcetylcholinesteraseNFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NaV (Voltage-gated sodium channels)PDE1 (Phosphodiesterase 1)CaV (Voltage-gated calcium channel protein complex)FFAR1 (Free fatty acid receptor 1)TBX3 (T-box transcription factor TBX3)

Beyond the preview

Go deeper on Vincamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vincamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call